{"url_path":"/sec/fbrx/8-k/2026-06-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1419041/0001193125-26-253436-index.html","accession_number":"0001193125-26-253436","cik":"0001419041","ticker":"FBRX","issuer_name":"Forte Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1419041/0001193125-26-253436-index.html","primary_entity_key":"0001419041","primary_entity_name":"Forte Biosciences, Inc."},"word_count":80,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d)  Exhibits\n\n \n\nExhibit\n  \n\nDescription\n\n10.1\n  \n[Amended and Restated 2021 Equity Incentive Plan](d110060dex101.htm)\n\n104\n  \nThe cover page of this Current Report on Form 8-K, formatted in inline XBRL.\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nFORTE BIOSCIENCES, INC.\n\nDate: June 2, 2026\n \n\n \nBy:\n \n\n/s/ Antony Riley\n\n \n\n \n\n \nAntony Riley\n\n \n\n \n\n \nChief Financial Officer"}